Shopping Cart
- Remove All
Your shopping cart is currently empty
BCX 1470 inhibits the esterolytic activity of factor D and C1s (IC50: 96 nM and 1.6 nM), demonstrating 3.4- and 200-fold greater efficacy compared to trypsin, respectively.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,520 | 1-2 weeks | |
| 50 mg | $1,980 | 1-2 weeks | |
| 100 mg | $2,500 | 1-2 weeks |
| Description | BCX 1470 inhibits the esterolytic activity of factor D and C1s (IC50: 96 nM and 1.6 nM), demonstrating 3.4- and 200-fold greater efficacy compared to trypsin, respectively. |
| Targets&IC50 | C1s:1.6 nM , Trypsin:326 nM , FD:96 nM |
| In vitro | BCX 1470 is an inhibitor serine protease. BCX 1470 blocks the esterolytic and hemolytic activities of the complement enzymes Cls and factor D in vitro. |
| In vivo | BCX 1470 blocked the development of RPA-induced edema in the rat. |
| Molecular Weight | 302.37 |
| Formula | C14H10N2O2S2 |
| Cas No. | 217099-43-9 |
| Relative Density. | 1.52 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.